| 000 | 01874 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517125934.0 | ||
| 264 | 0 | _c20170906 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1473-0766 | ||
| 024 | 7 |
_a10.1080/09513590.2016.1260110 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerdomo, Carolina M | |
| 245 | 0 | 0 |
_aManagement of a pregnant woman with thyrotropinoma: a case report and review of the literature. _h[electronic resource] |
| 260 |
_bGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology _cMar 2017 |
||
| 300 |
_a188-192 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdenoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperthyroidism _xetiology |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm, Residual |
| 650 | 0 | 4 |
_aOctreotide _xadministration & dosage |
| 650 | 0 | 4 |
_aOrgan Sparing Treatments _xadverse effects |
| 650 | 0 | 4 |
_aPituitary Gland _xdrug effects |
| 650 | 0 | 4 |
_aPituitary Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Neoplastic _xdrug therapy |
| 650 | 0 | 4 | _aTerm Birth |
| 650 | 0 | 4 |
_aThyrotropin _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aÁrabe, Jorge A | |
| 700 | 1 | _aIdoate, Miguel Á | |
| 700 | 1 | _aGalofré, Juan C | |
| 773 | 0 |
_tGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology _gvol. 33 _gno. 3 _gp. 188-192 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/09513590.2016.1260110 _zAvailable from publisher's website |
| 999 |
_c26660570 _d26660570 |
||